PELLEGATA, NATALIA SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 753
EU - Europa 542
AS - Asia 240
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.538
Nazione #
US - Stati Uniti d'America 742
IE - Irlanda 199
CN - Cina 193
FI - Finlandia 75
IT - Italia 69
UA - Ucraina 62
DE - Germania 60
SG - Singapore 33
SE - Svezia 30
GB - Regno Unito 14
FR - Francia 12
CA - Canada 10
BE - Belgio 7
RU - Federazione Russa 6
JP - Giappone 5
AT - Austria 4
PK - Pakistan 3
HK - Hong Kong 2
NL - Olanda 2
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
IL - Israele 1
IR - Iran 1
LV - Lettonia 1
MU - Mauritius 1
TR - Turchia 1
VN - Vietnam 1
Totale 1.538
Città #
Dublin 196
Chandler 186
Boardman 75
Ashburn 62
Jacksonville 60
Nanjing 55
Helsinki 45
Lawrence 32
Princeton 32
Medford 30
Wilmington 28
Singapore 24
Falkenstein 20
Beijing 19
Hebei 19
Jiaxing 17
Nanchang 17
Milan 16
Shanghai 14
Changsha 13
Shenyang 13
Chicago 10
Tianjin 10
Ann Arbor 9
Germering 9
Pavia 9
Toronto 9
Seattle 8
Brussels 7
Monza 6
Verona 6
Padova 5
Secaucus 5
Tokyo 5
Falls Church 4
Hangzhou 4
Los Angeles 4
Alessandria 3
Dallas 3
Florence 3
Munich 3
Norwalk 3
Vienna 3
Bolzano 2
Cepagatti 2
Des Moines 2
Fairfield 2
Guangzhou 2
Hong Kong 2
New York 2
Washington 2
Woodbridge 2
Ardabil 1
Auburn Hills 1
Blainville 1
Brno 1
Cairo 1
Changchun 1
Chengdu 1
Frankfurt am Main 1
Ho Chi Minh City 1
Kemerovo 1
L'aquila 1
Lanzhou 1
Mersin 1
Moscow 1
Pescara 1
Phoenix 1
Rehovot 1
Riga 1
Rockville 1
San Francisco 1
San José 1
Santa Clara 1
Springfield 1
Wuppertal 1
Totale 1.143
Nome #
Effects of topoisomerase II inhibitors on gastric cancer cells characterized by different genetic lesions 78
Analysis and clinical implications of K-ras gene mutations and infection with human papillomavirus types 16 and 18 in primary adenocarcinoma of the uterine cervix 78
K-ras gene mutations: an unfavorable prognostic marker in stage I lung adenocarcinoma 72
Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. 66
Loss of heterozygosity and K-ras gene mutations in gastric cancer 65
Genetic events in sporadic colorectal adenomas; K-ras and p53 heterozygous mutations are not sufficient for malignant progression 63
Primary retroperitoneal mucinous cystoadenocarcinomas: an immunohistochemical and molecular study 62
K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions 59
Study on aneuploidy and p53 mutations in astrocytomas 55
Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients 55
The significance of p53 mutations in human cancers 52
Detection of K-ras mutations by denaturing gradient gel electrophoresis (DGGE): a study on pancreatic cancer 49
A 5'-truncated c-myc gene variant not associated with a risk of cancer 49
Gene amplification and proliferative kinetics in relation to prognosis of patients with gastric carcinoma 48
Base transitions are the most frequent genetic changes at P53 in gastric cancer 45
Aip-mutated acromegaly resistant to first-generation somatostatin analogs: Long-term control with pasireotide lar in two patients 45
Mutation of the Cell Cycle Regulator p27kip1 Drives Pseudohypoxic Pheochromocytoma Development 44
Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects 37
Characterization of neuroendocrine tumors in heterozygous mutant MENX rats: A novel model of invasive medullary thyroid carcinoma 35
Adiponectin affects the mechanical responses in strips from the mouse gastric fundus 34
CDKN1B (p27) defects leading to pituitary tumors 32
Imaging pheochromocytoma in small animals: preclinical models to improve diagnosis and treatment 32
The glucocorticoid receptor in brown adipocytes is dispensable for control of energy homeostasis 30
Animal models of MEN1 29
The norepinephrine transporter as a putative predictive biomarker for PI3K/mTOR inhibition in pheochromocytoma. 28
miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance 27
Multiple Endocrine Neoplasia Type 4 (MEN 4) 27
Adipocyte-specific tribbles pseudokinase 1 regulates plasma adiponectin and plasma lipids in mice 26
Obesity and cancer – extracellular matrix, angiogenesis, and adrenergic signaling as unusual suspects linking the two diseases 25
Multiple Endocrine Neoplasia-Type 4 (MEN4) and Other MEN1-Like Syndromes 24
Editorial: Stem Cells in Endocrine Tumors 22
Angpt2/Tie2 autostimulatory loop controls tumorigenesis 20
Gender-specific efficacy revealed by head-to-head comparison of pasireotide and octreotide in a representative in vivo model of nonfunctioning pituitary tumors 19
Animal models of multiple endocrine neoplasia 18
Multiple Endocrine Neoplasia Type 4 15
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures 15
Animal and Cell Culture Models of PPGLs – Achievements and Limitations 12
Targeting PI3K/mTOR signaling exerts potent antitumor activity in pheochromocytoma in vivo 8
Tribbles Genes in Gastric Cancer: A Tumor-Suppressive Role for TRIB2 8
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 6
Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging 6
Morphology, Biochemistry, and Pathophysiology of MENX-Related Pheochromocytoma Recapitulate the Clinical Features 5
Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome 5
An AMP-activated protein kinase–stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice 5
Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas 4
Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome 4
Ovarian hyperstimulation from ectopic hypersecretion of follicle stimulating hormone 4
Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort study 4
Early onset acromegaly associated with a novel deletion in CDKN1B 5′UTR region 4
SSTR3 is a putative target for the medical treatment of gonadotroph adenomas of the pituitary 4
Obesity in MENX Rats Is Accompanied by High Circulating Levels of Ghrelin and Improved Insulin Sensitivity 4
Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma 3
Targeting PI3K/mTOR Signaling Displays Potent Antitumor Efficacy against Nonfunctioning Pituitary Adenomas 3
Preclinical evaluation of 18F-LMI1195 for in vivo imaging of pheochromocytoma in the MENX tumor model 3
Analysis of mammalian gene function through broad-based phenotypic screens across a consortium of mouse clinics 3
Simultaneous magnetic resonance imaging of pH, perfusion and renal filtration using hyperpolarized 13C-labelled Z-OMPD 3
Primary Cell Culture Systems for Human Thyroid Studies 3
Inceptor correlates with markers of prostate cancer progression and modulates insulin/IGF1 signaling and cancer cell migration 3
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas 3
Totale 1.587
Categoria #
all - tutte 9.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.773


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202047 0 0 0 0 0 10 0 13 0 14 10 0
2020/202195 10 8 3 10 0 13 8 13 3 12 12 3
2021/2022156 0 0 10 6 1 7 2 24 8 4 15 79
2022/2023550 44 47 4 31 63 59 2 31 246 3 12 8
2023/2024259 19 50 12 21 20 30 41 31 1 14 11 9
2024/2025190 20 64 9 20 8 69 0 0 0 0 0 0
Totale 1.587